Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Dendreon Corp
(NQ:
DNDN
)
4.080
USD
-0.020 (-0.49%)
Official Closing Price
/ Updated:
4:00 PM EDT, Jun 18, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Stories about Dendreon Corp
< Previous
1
2
3
4
5
6
7
8
9
...
51
52
Next >
Dendreon Shocks Market With PROVENGE Sales Decline In Q1 2013
May 09, 2013
Today Dendreon (NASDAQ: DNDN) shocked the market after reporting an extremely disappointing $67.6 M in PROVENGE (sipuleucel-T) sales for Q1 2013, representing a 17.56% decline relative to $82 M in...
Read More
category
Bio/Wire
,
DNDN
from
Bio-Wire.Com
Dendreon Corp (DNDN) Reports In-Line Q1 Loss of 48c/Share
May 09, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8321026 for the full story.
Read More
from
StreetInsider.com News Articles
Dendreon Corp (DNDN) halted, news pending
May 09, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8320934 for the full story.
Read More
from
StreetInsider.com News Articles
Dendreon (DNDN) - Market Digest
May 09, 2013
NEW YORK (AVAFIN) -- Options traders were heavily trading options contracts during the market ...
Read More
from
AVAFIN
Trading Radar for 05/09: priceline.com (PCLN), NVIDIA (NVDA), DISH Network (DISH), Dean Foods (DF) Report
May 08, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8318004 for the full story.
Read More
from
StreetInsider.com News Articles
StockCall Pre-Market Review on DNDN, SRPT, ACAD, CTIC, and MDVN
May 08, 2013
from
ACCESSWIRE
Bracing for Dendreon Q1 2013 Earnings – All Eyes On PROVENGE
May 08, 2013
Today, Dendreon (NASDAQ: DNDN) shareholders will brace for the company’s Q1 2013 earnings, which will be discussed in a conference call on Thursday at 9:00 AM EDT. Dendreon, which has been operating at...
Read More
category
Bio/Wire
,
DNDN
from
Bio-Wire.Com
The Week Ahead: Host of Earnings on Tap; Investors Watching Anadarko, Activision, and Whole Foods
May 03, 2013
The upcoming trading week will see a host of companies releasing their quarterly results as earnings season continues in high gear. Investors will also be focused on key economic data set to be...
Read More
category
Earnings
,
Benzinga
,
Global
, and 50 more.
from
Latest Articles from Benzinga.com
Short Sellers Move into Celgene, Regeneron
April 26, 2013
The short interest moves in biotech and emerging pharmaceutical companies were mixed in the first two weeks of April. The number of shares sold short in Alexion Pharmaceuticals (NASDAQ: ALXN ), Amgen...
Read More
category
Regeneron Pharmaceuticals
,
amgen
,
Benzinga
, and 34 more.
from
Latest Articles from Benzinga.com
Highlights on Options Trading for Dendreon
April 23, 2013
NEW YORK (AVAFIN) -- Unusual volume of DNDN put contracts exchanged hands yesterday ...
Read More
from
AVAFIN
AVEO Poised To Move Higher Before May 2 FDA Adcomm Catalyst, Obama Care, And Platform Potential
April 15, 2013
category
Pharmaceuticals
from
Trefis
Friday's ETF with Unusual Volume: BBH
April 12, 2013
The Biotech ETF (BBH) is seeing unusually high volume in afternoon trading Friday, with over 102,000 shares traded versus three month average volume of about 59,000. Shares of BBH were up about 0.9% on...
Read More
category
ETFs
from
ETF Channel
Short Sellers Move Out of Amgen, Celgene, Pharmacyclics
April 10, 2013
The short interest in biotech and emerging pharmaceutical companies was mixed in the final two weeks of March. The number of shares sold short in Alexion Pharmaceuticals (NASDAQ: ALXN ), Arena...
Read More
category
Regeneron Pharmaceuticals
,
amgen
,
Benzinga
, and 32 more.
from
Latest Articles from Benzinga.com
New Battleground Emerges For Dendreon Bulls & Bears
April 07, 2013
New Battleground Emerges For Dendreon Bulls & Bears The fierce and unending battle between Dendreon (NASDAQ: DNDN) bulls and bears has entered new territory: TV advertising. In a rather unconventional...
Read More
category
Brian L/ Wilson
,
DNDN
from
Bio-Wire.Com
3 Small Cap Biopharmas Primed To Move Much Higher Now
March 27, 2013
With the current record market run, small cap biopharmas have kept pace and continue to trend higher, being one of the best sectors for both trading and investing over the past year. With 39 new drugs...
Read More
category
ONXX
,
ACAD
,
Scott Matusow
, and 2 more.
from
Bio-Wire.Com
Dendreon - Trade Flow Report
March 25, 2013
NEW YORK (AVAFIN) -- Financial institutions traded 16 block trades on shares of Dendreon. ...
Read More
from
AVAFIN
Dendreon (DNDN) Settles PROVENGE Class Action
March 18, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8191440 for the full story.
Read More
from
StreetInsider.com News Articles
Trading Analysis for Dendreon
March 15, 2013
NEW YORK (AVAFIN) -- DNDN options contracts experienced interesting volume on the put ...
Read More
from
AVAFIN
Short Interest Swings in Biotech Stocks (AMGN, CELG, PCYC)
March 12, 2013
The short interest in biotech and emerging pharmaceutical companies was mixed again in the final two weeks of February. The number of shares sold short in Alexion Pharmaceuticals (NASDAQ: ALXN ), Arena...
Read More
category
Regeneron Pharmaceuticals
,
amgen
,
Benzinga
, and 33 more.
from
Latest Articles from Benzinga.com
How Cancer Beats the Immune System
March 06, 2013
from
ACCESSWIRE
Notable Analyst Rating Changes 03/06: (DF) (BBY) (FSLR) Upgraded; (AAPL) (JCP) (DNDN) Downgraded
March 06, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8161600 for the full story.
Read More
from
StreetInsider.com News Articles
ISI Group Downgrades Dendreon (DNDN) to Neutral
March 06, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8161150 for the full story.
Read More
from
StreetInsider.com News Articles
Dendreon (DNDN) 2013 Annual Meeting Set for April 22
March 04, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8153326 for the full story.
Read More
from
StreetInsider.com News Articles
Small Companies Are Hubs of Future Profit in Regenerative Medicine: Gil Van Bokkelen
March 01, 2013
category
Pharmaceuticals
from
Trefis
Short Interest Swings in Biotech Stocks (ALXN, AMGN, CELG)
February 28, 2013
The short interest in biotech and emerging pharmaceutical companies was mixed again in the first two weeks of February. The number of shares sold short in Arena Pharmaceuticals (NASDAQ: ARNA ),...
Read More
category
Regeneron Pharmaceuticals
,
amgen
,
Benzinga
, and 35 more.
from
Latest Articles from Benzinga.com
Top Analyst Upgrades and Downgrades (ARO, MO, ADM, ATML, CL, CVRR, DNDN, IGT, IP, NKE, LULU, LOW, LSI, OKS, SNDK, TEF, TPH, YUM, CQP, LNG)
February 26, 2013
DailyFinance.com : These are some of this Tuesday's top analyst upgrades, downgrades and initiations seen from Wall St. research calls. Aeropostale Inc. (NYSE: ARO) named Bear of the Day as expensive...
Read More
category
atml
,
dndn
,
cl
, and 17 more.
from
DailyFinance.com
Stocks Crossing 50-Day SMA 02/25: (SIRI) (LBTYA) Above; (LOW) (DNDN) Below
February 25, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8129490 for the full story.
Read More
from
StreetInsider.com News Articles
Bearish Analyst Comments on Dendreon (DNDN)
February 25, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8129098 for the full story.
Read More
from
StreetInsider.com News Articles
Dendreon (DNDN) down on Q4 loss
February 25, 2013
Dendreon (NASDAQ: DNDN) moved down 1.6% to $5.67. Dendreon posted a Q4 loss. Share volume was 4.2 million, compared to an all-day average of 6.4 million
Read More
from
BAYSTREET RSS FEED
UPDATE 1-Dendreon posts 4th-quarter loss versus year-ago profit
February 25, 2013
Feb 25 (Reuters) - Dendreon Corp reported a quarterly loss versus a year-ago profit on Monday as revenue fell and restructuring costs weighed on the biotechnology company.
Read More
category
companyNews
from
Reuters: Company News
< Previous
1
2
3
4
5
6
7
8
9
...
51
52
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here